Cell Transplantation, 2018 · DOI: 10.1177/0963689718766279 · Published: June 1, 2018
This study explores a new treatment for complete spinal cord injuries (SCI) using collagen scaffolds, called NeuroRegen scaffolds, combined with human umbilical cord mesenchymal stem cells (MSCs). These scaffolds were implanted into the injury site of two patients diagnosed with acute complete SCI. The researchers used a strict method to diagnose the patients as having complete SCI, combining the American Spinal Injury Association (ASIA) Impairment Scale, MRI scans, and nerve electrophysiology. This is important because it helps ensure that the patients truly had complete injuries before treatment. After one year, the patients showed improvements in both sensory and motor functions. One patient could walk with assistance, and the other regained some leg movement. The study suggests this combined approach could be a promising treatment for acute complete SCI.
The study suggests that NeuroRegen scaffolds with MSCs could offer a new treatment option for acute complete SCI, which currently has limited effective treatments.
The combined diagnostic criteria used in this study may improve the accuracy of diagnosing acute complete SCI, leading to more appropriate treatment strategies.
The observed functional recovery in patients indicates the potential for improving the quality of life for individuals with severe spinal cord injuries.